<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91DA30EC-86C6-41D7-B9B5-5F79F1F73FA7"><gtr:id>91DA30EC-86C6-41D7-B9B5-5F79F1F73FA7</gtr:id><gtr:name>European Molecular Biology Laboratory</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F7D6549F-4CA9-45BA-8E0A-187C8C0A0706"><gtr:id>F7D6549F-4CA9-45BA-8E0A-187C8C0A0706</gtr:id><gtr:name>University of the Balearic Islands</gtr:name><gtr:address><gtr:line1>Cra. De Valldemossa</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/296E9ACC-110A-423D-8149-8E13836C235B"><gtr:id>296E9ACC-110A-423D-8149-8E13836C235B</gtr:id><gtr:name>Chinese University of Hong Kong</gtr:name><gtr:address><gtr:line1>Chinese University of Hong Kong</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:department>Thornton Group</gtr:department><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9A22541F-DA58-481E-8D0C-C4BCF4EA030E"><gtr:id>9A22541F-DA58-481E-8D0C-C4BCF4EA030E</gtr:id><gtr:name>EMBL - European Bioinformatics Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB10 1SD</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060"><gtr:id>C0E4FAD2-3C8B-410A-B6DF-3B9B9E433060</gtr:id><gtr:name>University of St Andrews</gtr:name><gtr:address><gtr:line1>College Gate</gtr:line1><gtr:line4>St. Andrews</gtr:line4><gtr:line5>Fife</gtr:line5><gtr:postCode>KY16 9AJ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91DA30EC-86C6-41D7-B9B5-5F79F1F73FA7"><gtr:id>91DA30EC-86C6-41D7-B9B5-5F79F1F73FA7</gtr:id><gtr:name>European Molecular Biology Laboratory</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7D6549F-4CA9-45BA-8E0A-187C8C0A0706"><gtr:id>F7D6549F-4CA9-45BA-8E0A-187C8C0A0706</gtr:id><gtr:name>University of the Balearic Islands</gtr:name><gtr:address><gtr:line1>Cra. De Valldemossa</gtr:line1><gtr:region>outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/296E9ACC-110A-423D-8149-8E13836C235B"><gtr:id>296E9ACC-110A-423D-8149-8E13836C235B</gtr:id><gtr:name>Chinese University of Hong Kong</gtr:name><gtr:address><gtr:line1>Chinese University of Hong Kong</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/2D0622E8-0A38-4ACE-8AAA-740F40EACCD9"><gtr:id>2D0622E8-0A38-4ACE-8AAA-740F40EACCD9</gtr:id><gtr:firstName>Pedro</gtr:firstName><gtr:surname>Ballester Aristin</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0902106"><gtr:id>D14C8B4D-91AA-449E-9E30-81070C239A1A</gtr:id><gtr:title>New computational methods for protein function prediction using structural, binding and sequence data</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0902106</gtr:grantReference><gtr:abstractText>One aspect of my work is to develop statistical methods to analyse data from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Data from this trial consists of up to six annual sets of questionnaires from each participant. The questionnaires assess anxiety, sexual function and acceptability of the screening process. I will model how these three processes change over time, and how they depend on one another. There are several approaches to analysing this type of data, and I will explore the pros and cons of three different methods. The challenge in this work lies in the complexity of the UKCTOCS data-set. I will also use some of these methods to analyse data from the MRC Cognitive Function and Ageing Study.

A second aspect of my work is to develop methods for use in meta-analysis. Meta-analysis refers to the pooling of data from different studies, and is used to provide an overview of the available evidence. I will investigate methods for the meta-analysis of data which consists of times to events. I will also explore the meta-analysis of treatment `networks?, investigating the relative effects of a set of treatments for a given condition.</gtr:abstractText><gtr:technicalSummary>Structural Genomics projects determine a large number of protein structures that have little or no

functional information associated with them. Therefore, there is an increasing need for tools to

analyse and characterise the possible functional attributes of such structures. The main objective of

the proposed research is to investigate, implement and validate new methods for protein function

prediction exploiting the fast growing volume of publicly available structural, binding and sequence

data.

A full suite of protein function prediction tools (ProFunc) based on principles such as having similar

sequence, fold or binding sites has been recently developed at the European Bioinformatics Institute

(EBI). Experience shows that no single method, either sequence-based or structure-based, provides

a high proportion of correct predictions in all cases. Furthermore, methods exploiting binding data

are not currently incorporated to this holistic effort. This is in contrast with the imminent availability

of StARLite, a medicinal chemistry database containing vast bioactivity data, which constitutes an

extremely valuable resource for the development of such methods.

In order to fill this gap, a new method for protein function prediction exploiting StARLite binding

data will be investigated and ultimately integrated with ProFunc using an automatic consensus

protocol. This class of methods are based on the principle that protein binding similar sets of

molecules are likely to have similar biochemical function, which means that their effectiveness is

limited by our ability to predict protein-ligand binding via docking techniques. The candidate has

recently developed a very promising machine learning based improvement to docking. The massive

volume of structural and binding data that will be used for machine learning training, allied with the

availability CREDO?s detailed characterisation of inter-molecular interactions, means that the

methodology will be made even more accurate in the course of the fellowship.

The successful outcome of the proposed research will represent a major advance in our ability to

predict the biochemical function of new structures from Structural Genomics projects. Also, this

investigation is expected to increase our understanding of what combination of structural, binding

and sequence features confer biochemical function. Furthermore, the proposed chemogenomics

studies will improve drug target validation and polypharmacological drug lead profiling. In addition,

improved docking will permit more effective identification of biologically active molecules as a way

to reduce expensive and slow empirical High-Throughput Screening. Overall, the widespread

application of these methodologies would strongly contribute to the understanding and exploitation

of biological systems (e.g. pharmaceutical discovery).</gtr:technicalSummary><gtr:fund><gtr:end>2014-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>400905</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chinese University of Hong Kong</gtr:collaboratingOrganisation><gtr:country>Hong Kong, Special Administrative Region of China</gtr:country><gtr:department>Department of Computer Science and Engineering</gtr:department><gtr:description>Prof Kwong-Sak Leung (CUHK, China)</gtr:description><gtr:id>5CE42AF3-F99B-406A-9CC8-1854B814F6ED</gtr:id><gtr:impact>This is a multi-disciplinar collaboration involving computer science, computational chemistry and structural bioinformatics.</gtr:impact><gtr:outcomeId>UyMDwEU7fBM-1</gtr:outcomeId><gtr:partnerContribution>They have developed idock and the web server that runs it for prospective virtual screening of any target with a structural model.</gtr:partnerContribution><gtr:piContribution>Providing the docking scoring RF-Score and designing validation of the docking tool that uses it (idock).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of the Balearic Islands</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:description>Dr Jose Luis Rossello (Universidad de las Islas Baleares, Spain)</gtr:description><gtr:id>0B4A1DB0-203D-428E-9C65-51C7725B1E54</gtr:id><gtr:impact>I am co-investigator in a recently awarded Spanish National Plan grant (ref.TEC2011-23113, amount: ?55,400). It is a multi-disciplinary collaboration involving electronic engineering and computer science as well as chemical informatics and computational drug design.</gtr:impact><gtr:outcomeId>FUD66cDLFje-1</gtr:outcomeId><gtr:partnerContribution>I am co-investigator in a recently awarded Spanish National Plan grant (ref.TEC2011-23113, amount: ?55,400). The grant will fund a PhD student to investigate the implementation of faster vector similarity calculations using hardware-implemented stochastic-based processing (conventionally this is done via software). In the context of my MRC research, this new technology could be eventually applied to run molecular similarity techniques in a much faster way.</gtr:partnerContribution><gtr:piContribution>My role is limited to advise how this new technology could be applied to the area of drug lead identification.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Prof Chris Abell (University of Cambridge, UK)</gtr:description><gtr:id>3B460DDC-16C4-4F8F-AD4A-6AEBDA866FB2</gtr:id><gtr:impact>A joint publication: http://rsif.royalsocietypublishing.org/content/early/2012/08/23/rsif.2012.0569.abstract

This was a multi-disciplinary collaboration. The disciplines involved were: computational chemistry, structural bioinformatics and drug discovery.</gtr:impact><gtr:outcomeId>kwJjFLRtrQu-1</gtr:outcomeId><gtr:partnerContribution>Prof Abell's group carried out in vitro assays to validate the prediction of our computational models. This resulted in a high proportion of new inhibitors for the studied anti-TB drug target.</gtr:partnerContribution><gtr:piContribution>I led this multi-disciplinary collaboration, carried out most of the computational work and wrote the manuscript.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Molecular Biology Laboratory</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>European Molecular Biology Laboratory Heidelberg</gtr:department><gtr:description>Dr Maja Koehn (EMBL-Heidelberg, Germany)</gtr:description><gtr:id>CEB404A8-C08A-4704-8267-AE865E889D0E</gtr:id><gtr:impact>This is a multi-disciplinary collaboration involving chemical biology, medicinal chemistry and computational drug design.

A number of PRL-3 inhibitors have been identified by the developed methods. These are currently being used as proof-of-concept to raise additional funding and the plan is to patent them soon.</gtr:impact><gtr:outcomeId>XA5rSs9p1mo-1</gtr:outcomeId><gtr:partnerContribution>This lab has expertise in phosphatases and cancer biology; they carry out experimental validations and medicinal chemistry optimisation of the leads.</gtr:partnerContribution><gtr:piContribution>I have applied the developed ligand-based and structure-based virtual screening tools to discover new drug leads for PRL-3, a research target for colon cancer metastasis.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Prof Sir Tom Blundell (University of Cambridge, UK)</gtr:description><gtr:id>E526C63E-5124-485A-B26C-D78020757766</gtr:id><gtr:impact>This is a multi-disciplinary collaboration involving machine learning, structural and drug discovery informatics.

Main outputs are a joint paper in review and freely available software (see URL above).</gtr:impact><gtr:outcomeId>maauSAZ6d4U-1</gtr:outcomeId><gtr:partnerContribution>Providing detailed chemical descriptions of protein-ligand structural environment necessary for the modelling above.</gtr:partnerContribution><gtr:piContribution>Built and tested machine-learning predictors of binding for structure-based drug design mainly.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physics?&amp; Astronomy</gtr:department><gtr:description>Dr Jochen Blumberger (University College London, UK)</gtr:description><gtr:id>CC8B3283-CAAC-4C3E-A73B-45C0CA816137</gtr:id><gtr:impact>A joint publication: http://rsif.royalsocietypublishing.org/content/early/2012/08/23/rsif.2012.0569.abstract

This was a multi-disciplinary collaboration. The disciplines involved were: computational chemistry, structural bioinformatics and drug discovery.</gtr:impact><gtr:outcomeId>ZZYVyGUUrob-1</gtr:outcomeId><gtr:partnerContribution>Dr Blumberger model the interactions between putative small molecule bindings and the x-ray structural model of the drug target.</gtr:partnerContribution><gtr:piContribution>I led this multi-disciplinary collaboration (I am corresponding author), carried out most of the computational work and wrote the manuscript.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Prof Dame Janet Thornton (EMBL-EBI, UK)</gtr:description><gtr:id>9AD9024C-183E-44D9-8FE8-6197301A84CB</gtr:id><gtr:impact>This is a recent multi-disciplinary collaboration involving structural bioinformatics, aging biology and machine learning.</gtr:impact><gtr:outcomeId>skgNS5N8ySr-1</gtr:outcomeId><gtr:partnerContribution>My collaborators have compiled all these structures including homologues of model organisms and use the predicted strength of binding as an additional criterion to assess
how likely is a drug to affect the life-span of c.elegans and drosophila.</gtr:partnerContribution><gtr:piContribution>I am applying the methods I have developed to predict the strength with which molecules bind to proteins involved in aging using the co-crystallised structures as input.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>EMBL European Bioinformatics Institute (EMBL - EBI)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Dr Julio Saez-Rodriguez (EMBL-EBI, UK)</gtr:description><gtr:id>782B9A7F-4A7F-4CB3-93AA-A080E2C7E1B3</gtr:id><gtr:impact>This is a multi-disciplinary collaboration involving machine learning modelling, chemical informatics, genomics and drug design.

There is already a joint publication: http://dx.plos.org/10.1371/journal.pone.0061318

A second study on drug repositioning is on the way. Prospective validation is currently taking place.</gtr:impact><gtr:outcomeId>ZFHCoq6MsGq-1</gtr:outcomeId><gtr:partnerContribution>My collaborators contribute with the pre-processing of phenotypic, chemical and genomic data as well as the validation and interpretation of the resulting models.</gtr:partnerContribution><gtr:piContribution>I led the methodological part of this collaboration intended to model cancer pharmacogenomics in order to understand how drug efficacy depends on the genome of an individual.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of St Andrews</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry St Andrews</gtr:department><gtr:description>Dr John Mitchell (University of St Andrews, UK)</gtr:description><gtr:id>C0C5D5F5-F8F0-45CB-BA69-2D19FDB3A08A</gtr:id><gtr:impact>Since the start of my MRC fellowship, this collaboration has resulted in a joint publication: http://www.ncbi.nlm.nih.gov/pubmed/21591735 

There is also a first paper that was published between the offer and the official start of my MRC fellowship: http://www.ncbi.nlm.nih.gov/pubmed/20236947

Yes, this collaboration involves three disciplines: machine learning, chemical informatics and structural bioinformatics.</gtr:impact><gtr:outcomeId>gJb3qn3bnKL-1</gtr:outcomeId><gtr:partnerContribution>Dr J.B.O.M. helped me to write a paper on this topic.</gtr:partnerContribution><gtr:piContribution>A subproject within my MRC fellowship is to improve a new class of generic scoring functions for in silico docking that my collaborator and I recently introduced. This collaboration led to a joint publication introducing some important considerations for both the correct understanding of these scoring functions and their experimental validation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release about a study recently published at the Journal of the Royal Society Interface</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EC467DBC-EBD7-4F69-88E8-E8316CC51095</gtr:id><gtr:impact>Preparing a press release with a journalist in my institute.

http://www.ebi.ac.uk/Information/News/press-releases/research-highlight-30082012-Ballester_Interfaces.html

So far it was viewed by many academic in other fields via twitter and my Cambridge college facebook page. I contacted the MRC press office, but found difficult to materialise their interest in a concrete promotion activity.</gtr:impact><gtr:outcomeId>AgcDJiXhxD2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Full-page interview in a spanish newspaper (leading newspaper in the Balearic Islands region with population 1.2 million)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E166C615-A3F9-497E-B3DB-E5FAC9E52517</gtr:id><gtr:impact>I explained my research to a lay audience.
Link to the online edition of the newspaper: http://www.diariodemallorca.es/2012/09/05

People was really interested about my research and felt that now had an idea what I am doing and what impact this kind of research has on their lifes.</gtr:impact><gtr:outcomeId>BACE1894Xie</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wolfson College</gtr:department><gtr:description>JRF Research Allowance 2011-12</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>6415221B-2C46-46F0-A7C0-56340F356F87</gtr:id><gtr:outcomeId>nG6Nv2rxabv</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wolfson College</gtr:department><gtr:description>JRF Research Allowance 2012-13</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>3930A6E1-582C-480E-BA08-8F767CA804F2</gtr:id><gtr:outcomeId>qTbUw2o3JKe</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wolfson College</gtr:department><gtr:description>JRF Research Allowance 2013-14</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>University of Oxford</gtr:fundingOrg><gtr:id>C9E643D3-BCC0-4C98-BCB5-583F981F132B</gtr:id><gtr:outcomeId>PYu3C1jpfK7</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel award for EMBO practical course</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>63165C43-D3D6-48F7-86AF-E37A90849178</gtr:id><gtr:outcomeId>LeuMi5YiHqS0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Travel expenses for invited talk at GSK (Tres Cantos, Madrid, Spain)</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>464A024C-6118-48CB-A0F2-57861EE92EDE</gtr:id><gtr:outcomeId>sTnDo1BTWem0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Royal Society - Nature consultation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>A18A5369-0755-4BB6-9611-A0C61DAB5C31</gtr:id><gtr:impact>Tomorrow's Giants was a major one-day conference on the future of science, co-hosted by the Royal Society and Nature. Tomorrow's Giants brought together scientists and policy makers to gather a vision of the next 50 years in science and discuss what would be needed to enable academic achievement of the highest quality in the future. 

Participation at the conference was by application. Over 200 scientists were selected to attend the event to discuss their future alongside a series of eminent speakers and leading decision-makers. More information at http://royalsociety.org/Tomorrows-giants</gtr:impact><gtr:outcomeId>KXQvBDVLPs7</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type><gtr:url>http://royalsociety.org/Tomorrows-giants</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>RF-Score is the first scoring function for molecular docking based on nonparametric machine learning. In a recent study (http://www.ncbi.nlm.nih.gov/pubmed/21591735), RF-Score has been shown to outperform 16 widely used scoring functions.</gtr:description><gtr:id>6F20D800-688A-4EDC-A6C6-837DA7D75E2B</gtr:id><gtr:impact>The release of the RF-Score software is improving the dissemination of these results.</gtr:impact><gtr:outcomeId>RhJBzMbHEWP</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>RF-Score software</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ebi.ac.uk/%7Epedrob/docs/RF-Score.zip</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a multithreaded virtual screening tool for flexible ligand docking.</gtr:description><gtr:id>870646D6-8726-45CE-B261-C524B8A475B3</gtr:id><gtr:impact>Researchers can use this technology without expensive maintenance, installation, computers or technical knowledge.</gtr:impact><gtr:outcomeId>G1T2GTrgs3P</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IDOCK web server</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://istar.cse.cuhk.edu.hk/idock/</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D706419A-E077-4C1B-81D0-DEA80C10F4F5</gtr:id><gtr:title>Ultrafast shape recognition: method and applications.</gtr:title><gtr:parentPublicationTitle>Future medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac7660b7edd226b48118d67c05f13966"><gtr:id>ac7660b7edd226b48118d67c05f13966</gtr:id><gtr:otherNames>Ballester PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1756-8919</gtr:issn><gtr:outcomeId>fE63UkqxCq5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DECFA0BA-899A-4596-B76B-6534D4121AF8</gtr:id><gtr:title>Bioisosteres in Medicinal Chemistry - BROWN:BIOISOSTERES MED CH O-BK</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f3b3df901bb9fe9dfd16114e4f161c3"><gtr:id>3f3b3df901bb9fe9dfd16114e4f161c3</gtr:id><gtr:otherNames>Ballester P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>9783527330157</gtr:isbn><gtr:outcomeId>T8fDAPcrZJX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ACEB56C-A360-4AE3-9C85-E83798AED608</gtr:id><gtr:title>Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac7660b7edd226b48118d67c05f13966"><gtr:id>ac7660b7edd226b48118d67c05f13966</gtr:id><gtr:otherNames>Ballester PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>pm_12525_25_22933186</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA78BB14-31A4-4DCB-ACB0-A5FD864ADAF9</gtr:id><gtr:title>Substituting random forest for multiple linear regression improves binding affinity prediction of scoring functions: Cyscore as a case study.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>545a61e9092065.02190776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1377DA77-55D1-4654-A183-1B19D0B7533E</gtr:id><gtr:title>Prospective virtual screening for novel p53-MDM2 inhibitors using ultrafast shape recognition.</gtr:title><gtr:parentPublicationTitle>Journal of computer-aided molecular design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4a0e5f7f0b18813103db095b409fdcf8"><gtr:id>4a0e5f7f0b18813103db095b409fdcf8</gtr:id><gtr:otherNames>Patil SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0920-654X</gtr:issn><gtr:outcomeId>doi_55f985985498ae85</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57912679-20C0-4501-A530-8EEDFE3DCC26</gtr:id><gtr:title>Ligand-Based Virtual Screening for the Discovery of Inhibitors for Protein Arginine Deiminase Type 4 (PAD4)</gtr:title><gtr:parentPublicationTitle>Journal of Postgenomics Drug &amp; Biomarker Development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0ac473384ee155ad24d169a242c7ead"><gtr:id>a0ac473384ee155ad24d169a242c7ead</gtr:id><gtr:otherNames>Mohd Basyaruddin Abdul Rahman C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>QMs9doJaLxy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>491A2385-385C-45AE-87E1-1C9A62AF6AD5</gtr:id><gtr:title>Comments on &amp;quot;leave-cluster-out cross-validation is appropriate for scoring functions derived from diverse protein data sets&amp;quot;: significance for the validation of scoring functions.</gtr:title><gtr:parentPublicationTitle>Journal of chemical information and modeling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac7660b7edd226b48118d67c05f13966"><gtr:id>ac7660b7edd226b48118d67c05f13966</gtr:id><gtr:otherNames>Ballester PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1549-9596</gtr:issn><gtr:outcomeId>hwCXHXQCCMW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E1D1259-B3F0-427E-AF77-4D0557135C88</gtr:id><gtr:title>Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/37abfa2bb204230189968513b5bede86"><gtr:id>37abfa2bb204230189968513b5bede86</gtr:id><gtr:otherNames>Menden MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12525_25_23646105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1201C849-1158-44DD-928B-78F98B23E5FF</gtr:id><gtr:title>Machine-learning scoring functions to improve structure-based binding affinity prediction and virtual screening.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. Computational molecular science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/19e697164be96f7c746b89d7bc5308d1"><gtr:id>19e697164be96f7c746b89d7bc5308d1</gtr:id><gtr:otherNames>Ain QU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1759-0884</gtr:issn><gtr:outcomeId>56e05bac2fc1a6.92344808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>26DEA760-AD5E-4C16-AEA0-4D05F4EE3D20</gtr:id><gtr:title>Does a more precise chemical description of protein-ligand complexes lead to more accurate prediction of binding affinity?</gtr:title><gtr:parentPublicationTitle>Journal of chemical information and modeling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac7660b7edd226b48118d67c05f13966"><gtr:id>ac7660b7edd226b48118d67c05f13966</gtr:id><gtr:otherNames>Ballester PJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1549-9596</gtr:issn><gtr:outcomeId>doi_55f9859854a2cd84</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F439C210-B6DF-4A58-9022-FF67211946D4</gtr:id><gtr:title>Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver.</gtr:title><gtr:parentPublicationTitle>European journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3e07eeb481d93d07e31e73f67edfd9f"><gtr:id>f3e07eeb481d93d07e31e73f67edfd9f</gtr:id><gtr:otherNames>Hoeger B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0223-5234</gtr:issn><gtr:outcomeId>doi_55faa1aa1fbc7bb0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8A8FF26-FAB8-48B4-B667-8F9EB02561DA</gtr:id><gtr:title>Improving AutoDock Vina Using Random Forest: The Growing Accuracy of Binding Affinity Prediction by the Effective Exploitation of Larger Data Sets.</gtr:title><gtr:parentPublicationTitle>Molecular informatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08e3e9b152d63bb3495d9a000cd75f74"><gtr:id>08e3e9b152d63bb3495d9a000cd75f74</gtr:id><gtr:otherNames>Li H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1868-1743</gtr:issn><gtr:outcomeId>doi_55f9859854861919</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0902106</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>